Illinois HB4203 amends the Illinois Insurance Code to require coverage for ovarian cancer surveillance tests for insureds at risk.
Illinois HB4203 amends the Illinois Insurance Code to mandate coverage for ovarian cancer surveillance tests for insureds at risk. It defines "at risk for ovarian cancer" to include having a high level of CA-125, as indicated by a blood test screening. "Surveillance tests for ovarian cancer" include all medically viable methods for detection and diagnosis, such as ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood test screenings. This Act takes effect January 1, 2028.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.